-
Mashup Score: 1
Program: Oral and Poster Abstracts Session: 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster II Hematology Disease Topics & Pathways: Research, Bleeding and Clotting, Translational Research, Diseases, thrombotic disorders Alexander B Pine, MD, PhD 1, Ayesha Butt, MD 2, Rolando Garcia-Milian, MLS, AHIP 3 *, Sean X Gu, MD, PhD 4 *, Valentina Restrepo, MD 5 *, Yu Pei Chock, MD, MPH 6 *, John Hwa, MD, PhD 7 *, Christopher Tormey, MD 8 *, Henry M Rinder, MD 9, George
Source: ash.confex.comCategories: General Medicine NewsTweet
-
Mashup Score: 17Paper: A 1,000-Genome Map for Multiple Myeloma and Its Precursor Stages, and Its Impact on Clinical Outcome - 23 day(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Genes, Cells and Algorithms: Novel Methods of Predicting Progression in MGUS and SMM Hematology Disease Topics & Pathways: Research, Translational Research, Bioinformatics, Genomics, Computational biology, Biological Processes, Technology and Procedures, Omics technologies Jean-Baptiste Alberge, PhD 1,2,3, Ankit K. Dutta, PhD 1,2,3 *, Andrea Poletti 1,4
Source: ash.confex.comCategories: General Medicine NewsTweet-
**Basic/Translational Abstracts: - 1019 A 1,000-Genome Map for Multiple Myeloma and Its Precursor Stages, and Its Impact on Clinical Outcome https://t.co/oSbzH0CDX6 -358 Combination with Cytotoxic Therapy and Checkpoint Blockade Overcomes Primary Resistance to BCMA Bispecific… https://t.co/MTRou3ET7G
-
-
Mashup Score: 0Webprogram Unavailable - 23 day(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: General Medicine NewsTweet-
RCT of Primary Prophylaxis w/ Weekly Alendronate Against Glucocorticoid-Induced Osteoporosis in Lymphoma Pts Treated w/ Steroid-Containing Chemotherapy [Dec 12, 2021] Jensen et al. Abstract 456 #ASH21 https://t.co/5hoV9HpqQh #lymsm #BoneHealth #SuppOnc HT @graham74GC
-
-
Mashup Score: 4Paper: Patient Preferences on Clinical Decision-Making in Myeloma: A 747-Patient Survey - 1 month(s) ago
Program: Oral and Poster Abstracts Session: 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster I Hematology Di sease Topics & Pathways: Clinical Practice (Health Services and Quality), Plasma Cell Disorders, Diseases, Lymphoid Malignancies Ghulam Rehman Mohyuddin, MD 1, Rajshekhar Chakraborty, MD 2, Katherine Berger 3 *, Ryan Winborg 4 *, Mason S. Barnes, B.S. 5 *, Jorge Arturo Hurtado Martinez, MD 5 *, Jay R. Hydren, PhD 5, Douglas W Sborov, MD 1, Amandeep Godara 1, Brian
Source: ash.confex.comCategories: General Medicine News, Partners & KOLsTweet-
RT @Taxkourel: https://t.co/b9up9OJ2zT by @ManniMD1 and @HealthTree : “the vast majority of patients choose the less toxic option that offe…
-
-
Mashup Score: 0Paper: Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma - 1 month(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 907. Outcomes Research: Plasma Cell Disorders: Frailty, Supportive Care, and Factors Impacting Outcomes Hematology Disease Topics & Pathways: Research, Adult, Elderly, Health outcomes research, Clinical Research, Plasma Cell Disorders, Health disparities research, Diseases, Patient-reported outcomes, Lymphoid Malignancies, Registries, Study Population, Human Jorge Arturo Hurtado Martinez, MD 1 *, Felipe Flores Quiroz, MD 1 *, Jennifer M. Ahlstrom, BA
Source: ash.confex.comCategories: General Medicine NewsTweet-
Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma [Dec 8, 2024] Martinez et al. #ASH27 Abst 706 https://t.co/l7SHPBwbna #mmsm HT @Taxkourel
-
-
Mashup Score: 3Webprogram Unavailable - 1 month(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: General Medicine NewsTweet-
Role of TNFRSF17 and GPRC5D Structural and Point Mutations in Resistance to Targeted Immunotherapies in Multiple Myeloma (MM) [Dec 10, 2022] Lee et al. Abst 101 #ASH22 https://t.co/uFh0vyd5mx #mmsm #CARTcell #PrecisionMedicine
-
-
Mashup Score: 0Webprogram Unavailable - 1 month(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: General Medicine NewsTweet-
Multiomics Profiling of Measurable Residual Disease (MRD) for Understanding the Biology of Ultra-Drug Resistance in Multiple Myeloma (MM) [Dec 10, 2022] @camilagdeblois et al. Abst 99 #ASH22 https://t.co/izMBdiswlP #mmsm #mmMRD https://t.co/Pqd9dhwohw
-
-
Mashup Score: 2Webprogram Unavailable - 1 month(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: General Medicine NewsTweet-
Revealing the Impact of Recurrent and Rare Structural Variations in Multiple Myeloma - @EHRustad et al. #ASH19 Abstract 576 https://t.co/kchnpIPzfs #mmsm #cagenome https://t.co/KsZkuJAS8R
-
-
Mashup Score: 4Paper: Patient Preferences on Clinical Decision-Making in Myeloma: A 747-Patient Survey - 1 month(s) ago
Program: Oral and Poster Abstracts Session: 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster I Hematology Di sease Topics & Pathways: Clinical Practice (Health Services and Quality), Plasma Cell Disorders, Diseases, Lymphoid Malignancies Ghulam Rehman Mohyuddin, MD 1, Rajshekhar Chakraborty, MD 2, Katherine Berger 3 *, Ryan Winborg 4 *, Mason S. Barnes, B.S. 5 *, Jorge Arturo Hurtado Martinez, MD 5 *, Jay R. Hydren, PhD 5, Douglas W Sborov, MD 1, Amandeep Godara 1, Brian
Source: ash.confex.comCategories: General Medicine News, Partners & KOLsTweet-
RT @Taxkourel: https://t.co/b9up9OJ2zT by @ManniMD1 and @HealthTree : “the vast majority of patients choose the less toxic option that offe…
-
-
Mashup Score: 0Paper: Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma - 1 month(s) ago
Program: Oral and Poster Abstracts Type: Oral Session: 907. Outcomes Research: Plasma Cell Disorders: Frailty, Supportive Care, and Factors Impacting Outcomes Hematology Disease Topics & Pathways: Research, Adult, Elderly, Health outcomes research, Clinical Research, Plasma Cell Disorders, Health disparities research, Diseases, Patient-reported outcomes, Lymphoid Malignancies, Registries, Study Population, Human Jorge Arturo Hurtado Martinez, MD 1 *, Felipe Flores Quiroz, MD 1 *, Jennifer M. Ahlstrom, BA
Source: ash.confex.comCategories: General Medicine NewsTweet-
Patient-Centered Care in Hematology: How Side Effect Severity Influences Decision-Making Autonomy in Relapsed Refractory Multiple Myeloma [Dec 8, 2024] Martinez et al. #ASH27 Abst 706 https://t.co/l7SHPBwbna #mmsm HT @Taxkourel
-
Proteomic Profiling of Different Antiphospholipid Antibody-Positive Phenotypes: Results from Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking (APS ACTION) Registry [Dec 10, 2023] @BenignHeme et al #ASH23 Abs 2575 https://t.co/ZESAMWfRkR #APLA #VTE https://t.co/BxEOjdX9iA